[en] Pancreatobiliary cancers (PBC) group pancreatic and biliary tract cancers and are among the cancers with
the lowest survival rate. Emerging data suggest that novel biomarker-specific targeted therapies can be
proposed for selected populations with survival benefit. This review summarises the scientific evidence to
test for these biomarkers in order to optimise the management of pancreatobiliary cancers, within the con-
text of the Belgian NGS convention
Disciplines :
Oncology
Author, co-author :
Hebran, Aline; Sciensano
Lambert, Frédéric ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques ; Centre Hospitalier Universitaire de Liège - CHU > > Service de génétique ; Université de Liège - ULiège > Faculté de Médecine > Form. doct. sc. méd. (paysage) ; Université de Liège - ULiège > Faculté de Médecine > Doct. scienc. médi.
Language :
English
Title :
Genetic and molecular biology in pancreatobiliary cancers: Testing for pancreatobiliary cancer in the context of the Belgian NGS convention
